124 related articles for article (PubMed ID: 6588395)
21. [Effects of mianserin on functions of ascending and descending monoaminergic systems, using experimental models (author's transl)].
Sakai Y; Deguchi T
Nihon Yakurigaku Zasshi; 1980 Apr; 76(3):213-25. PubMed ID: 6967847
[TBL] [Abstract][Full Text] [Related]
22. Interactions of phospholipids and free fatty acids with antidepressant recognition binding sites in rat brain.
Stockert M; Zieher LM; Medina JH
Adv Exp Med Biol; 1992; 318():325-30. PubMed ID: 1636501
[TBL] [Abstract][Full Text] [Related]
23. On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors.
Barbaccia ML; Brunello N; Chuang DM; Costa E
Neuropharmacology; 1983 Mar; 22(3 Spec No):373-83. PubMed ID: 6304555
[TBL] [Abstract][Full Text] [Related]
24. Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants.
Hrdina PD
Eur J Pharmacol; 1987 Jun; 138(2):159-68. PubMed ID: 3040430
[TBL] [Abstract][Full Text] [Related]
25. Chronic in vivo treatment with desmethylimipramine and mianserin does not alter adenosine A-1 radioligand binding in rat cortex.
Williams M; Risley EA; Robinson JL
Neurosci Lett; 1983 Jan; 35(1):47-51. PubMed ID: 6302607
[TBL] [Abstract][Full Text] [Related]
26. p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain.
Shirayama Y; Nishikawa T; Umino A; Takahashi K
Eur J Pharmacol; 1993 Jun; 237(1):117-26. PubMed ID: 8359206
[TBL] [Abstract][Full Text] [Related]
27. Chronic effects of imipramine and lithium on postsynaptic 5-HT1A and 5-HT1B sites and on presynaptic 5-HT3 sites in rat brain.
Mizuta T; Segawa T
Jpn J Pharmacol; 1988 Jun; 47(2):107-13. PubMed ID: 3199589
[TBL] [Abstract][Full Text] [Related]
28. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.
Rogóz Z; Skuza G; Legutko B
J Physiol Pharmacol; 2005 Dec; 56(4):661-71. PubMed ID: 16391422
[TBL] [Abstract][Full Text] [Related]
29. Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
Barbaccia ML; Gandolfi O; Chuang DM; Costa E
Neuropharmacology; 1983 Jan; 22(1):123-6. PubMed ID: 6843781
[TBL] [Abstract][Full Text] [Related]
30. A two-week treatment with antidepressants does not increase the density of 3H-prazosin binding sites in the cerebral cortex of elderly rats.
Nowak G
Pol J Pharmacol Pharm; 1987; 39(6):721-4. PubMed ID: 2847127
[TBL] [Abstract][Full Text] [Related]
31. Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational states.
Dumbrille-Ross A; Morris J; Davis A; Tang SW
Eur J Pharmacol; 1983 Aug; 91(4):383-9. PubMed ID: 6311587
[TBL] [Abstract][Full Text] [Related]
32. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs.
Klimek V; Zak-Knapik J; Cannizzaro C
Pol J Pharmacol Pharm; 1992; 44(6):549-60. PubMed ID: 1305956
[TBL] [Abstract][Full Text] [Related]
33. Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat.
Blier P; de Montigny C; Tardif D
Psychopharmacology (Berl); 1984; 84(2):242-9. PubMed ID: 6438684
[TBL] [Abstract][Full Text] [Related]
34. Relationship between levels and uptake of serotonin and high affinity [3H]imipramine recognition sites in the rat brain.
Hrdina PD; Pappas BA; Roberts DC; Bialik RJ; Ryan CL
Can J Physiol Pharmacol; 1985 Oct; 63(10):1239-44. PubMed ID: 3000552
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of two components of specific [3H]imipramine binding in rat brain.
Hrdina PD
Eur J Pharmacol; 1984 Jul; 102(3-4):481-8. PubMed ID: 6092098
[TBL] [Abstract][Full Text] [Related]
36. Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment.
Marcusson J; Bäckström IT; Ross SB
Psychopharmacology (Berl); 1988; 94(2):193-6. PubMed ID: 2965397
[TBL] [Abstract][Full Text] [Related]
37. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
Marcusson JO; Bäckström IT; Ross SB
Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
[TBL] [Abstract][Full Text] [Related]
38. Chronic lithium treatment decreases [3H]-imipramine binding in rat brain.
Maeda K; Tanimoto K; Terada T
Jpn J Psychiatry Neurol; 1986 Jun; 40(2):227-30. PubMed ID: 3784159
[TBL] [Abstract][Full Text] [Related]
39. Mianserin potentiates responses to acetylcholine in the rat anococcygeus muscle.
Doggrell SA
Eur J Pharmacol; 1979 May; 55(3):311-4. PubMed ID: 456428
[TBL] [Abstract][Full Text] [Related]
40. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
Kendall DA; Nahorski SR
J Pharmacol Exp Ther; 1983 Nov; 227(2):429-34. PubMed ID: 6631722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
